Purple Biotech Regains Nasdaq Compliance
Company Announcements

Purple Biotech Regains Nasdaq Compliance

Purple Biotech (PPBT) has released an update.

Purple Biotech Ltd. has successfully met the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as confirmed by the Nasdaq Listing Qualifications Department. The company’s American Depositary Shares maintained a closing bid price of at least $1.00 for over 10 consecutive business days, securing its compliance and closing the matter.

For further insights into PPBT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPurple Biotech Unveils Promising Biomarker for Cancer Therapy
TheFlyPurple Biotech identifies potential new serum biomarker for CM24
Brian AndersonPPBT Upcoming Earnings Report: What to Expect?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App